🔎 Trials Near Me

Akèy › Timè nan sèvo › Illinois › Chicago

Etid klinik pou Timè nan sèvo nan Chicago, IL

11 etid pou Timè nan sèvo ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Frameless Stereotactic Radiosurgery for Intact Brain Metastases

Ap rekriteFaz 2
  • University of Chicago, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02747303

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Ap rekriteFaz 1
  • University of Chicago, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06253871

Targeted Pediatric High-Grade Glioma Therapy

Ap rekriteEtid obsèvasyon
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
12 Months – 39 Years · Tout sèks · Mizajou Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Ap rekriteFaz 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Laj 12 a 39 · Tout sèks · Mizajou Sep 1, 2026 · NCT06161974

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

Ap rekriteFaz 2
  • Robert H. Lurie Comprehensive Cancer Center Northwestern University, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06764940

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

Ap rekriteFaz 2
  • Lurie Children's Hospital, Chicago
Laj 1 a 26 · Tout sèks · Mizajou Aug 4, 2026 · NCT07680439

REMASTer: REcurrent Brain Metastases After SRS Trial

Ap rekrite
  • University of Chicago, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT05124912

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Ap rekriteFaz 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
12 Months – 39 Years · Tout sèks · Mizajou May 29, 2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Ap rekriteFaz 1/2
  • Northwestern Memorial Hospital, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT06810544

Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery

Ap rekrite
  • University of Illinois at Chicago, Chicago
Laj 18 a 99 · Tout sèks · Mizajou Nov 12, 2025 · NCT07111182

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Ap rekriteFaz 3
  • John H Stroger Jr Hospital of Cook County, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Oct 8, 2025 · NCT03418961

Etid Timè nan sèvo nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.